Study Shows Statins Reduce Coenzyme Q in Brain Cells, Impairing Mitochondrial Function
A laboratory study found that statin drugs decrease coenzyme Q levels in astrocytes (brain support cells) by 30-40%, reducing their mitochondrial energy production and increasing oxidative stress. Astrocytes are critical for maintaining brain health and protecting neurons from damage. The findings suggest CoQ10 supplementation may help counteract these effects, though human clinical evidence remains limited.
Researchers exposed rat astrocytes to atorvastatin and simvastatin—common cholesterol-lowering statins—for six days and measured changes in mitochondrial function. The treatment reduced total mitochondrial coenzyme Q by 30-35% and the antioxidant form (mtCoQH2) by 40%, leading to decreased ATP production, reduced membrane potential, and increased hydrogen peroxide generation. The statins also disrupted the organization of respiratory chain complexes responsible for energy production. CoQ10 supplementation restored these functions in treated cells. While the study demonstrates a clear mechanistic link between statin use and mitochondrial dysfunction in brain cells, it is limited to laboratory conditions in rat cells and does not establish whether these effects occur at clinically relevant doses in human brains.
What's missing
The study does not address whether the observed mitochondrial changes occur in vivo at therapeutic statin doses in humans, whether they correlate with reported statin-associated cognitive or neurological symptoms, or what the clinical significance of a 30-40% CoQ reduction might be for astrocyte function in living organisms.
What different sources said
- bioRxivCenter
Statin-Induced Mitochondrial Coenzyme Q Deficiency Alters Mitochondrial Redox Homeostasis and Bioenergetic Function in Astrocytes
Related
Study reveals zebrafish larvae exhibit slowly fluctuating directional swim biases driven by internal dynamics
Researchers found that 5-day-old zebrafish larvae display changing directional swim preferences over many hours even in stable environments, contrary to classical models assuming constant individual biases. Computational analysis suggests these fluctuations arise from a non-stationary Markovian process with two independent internal input streams modulating swim direction repetition. The findings suggest animals possess intrinsic mechanisms for generating behavioral variability independent of external stimuli, with implications for understanding how internal states shape adaptive behavior.
Two Small Molecules Show Promise as Broad-Spectrum Coronavirus Inhibitors in Laboratory Study
Researchers found that sennoside A and ceftazidime, two small molecules, can inhibit RNA binding in the nucleocapsid proteins of SARS-CoV-2, SARS-CoV, and MERS-CoV in laboratory experiments. The nucleocapsid protein is highly conserved across coronaviruses and essential for viral replication, making it a potential drug target. The findings suggest these compounds could form the basis for pan-coronavirus antiviral therapies, though further development and clinical testing would be needed.
Fish skin microbiomes shift dramatically as species transition from aquatic to terrestrial habitats
Researchers studying three combtooth blenny fish species found that their skin microbiomes diverge significantly based on habitat, with the most terrestrial species showing the most distinct microbial communities. The study compared skin bacteria across species occupying different zones of the intertidal gradient in Guam, from fully aquatic to exclusively terrestrial environments. The findings suggest microbial symbionts may play a role in enabling amphibious lifestyles and provide insights into how microbiomes respond to environmental change.